{
  "abstract": "New advice to limit the use of nasal decongestant sprays containing xylometazoline and oxymetazoline to a maximum of five days has been issued by the UK’s drug regulator.",
  "authors": [
    {
      "affiliations": [
        "The BMJ"
      ],
      "name": "Gareth Iacobucci"
    }
  ],
  "title": "Limit use of nasal decongestant sprays to five days, UK regulator says",
  "uid": "8c141557-4a41-51bc-a69f-05bca278fa63"
}